EU expands use of Roche's Pegasys in chronic hepatitis C

ZURICH (Reuters) - Roche said on Monday the European Medicines Agency (EMA) has expanded the approval of its drug Pegasys plus ribavirin for the treatment of chronic hepatitis C virus (HCV) to children five years of age and older.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news